Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Neurobiol Dis. 2018 Sep 10;128:59–66. doi: 10.1016/j.nbd.2018.09.008

Dichotomy between motor and cognitive functions of midbrain cholinergic neurons

Nadine K Gut 1, Juan Mena-Segovia 1
PMCID: PMC7176324  NIHMSID: NIHMS1507318  PMID: 30213733

Abstract

Cholinergic neurons of the pedunculopontine nucleus (PPN) are interconnected with all the basal ganglia structures, as well as with motor centers in the brainstem and medulla. Recent theories put into question whether PPN cholinergic neurons form part of a locomotor region that directly regulates the motor output, and rather suggest a modulatory role in adaptive behavior involving both motor and cognitive functions. In support of this, experimental studies in animals suggest that cholinergic neurons reinforce actions by signaling reward prediction and shape adaptations in behavior during changes in environmental contingencies. This is further supported by clinical studies proposing that decreased cholinergic transmission originated in the PPN is associated with impaired sensorimotor integration and perseverant behavior, giving rise to some of the symptoms observed in Parkinson’s disease and progressive supranuclear palsy. Altogether, the evidence suggests that cholinergic neurons of the PPN, mainly through their interactions with the basal ganglia, have a leading role in action control.

Keywords: pedunculopontine, cholinergic, movement, behavioral arrest, gait, balance

Introduction

There has been an ongoing debate on whether cholinergic neurons of the pedunculopontine nucleus (PPN) have motor or cognitive roles. From the early experiments exploring the effects of electrical stimulation of the brainstem in decerebrate cats in the 1960s, to the varied outcomes of deep brain stimulation (DBS) in the PPN of Parkinson’s disease (PD) patients in recent years, the question about the nature of cholinergic neurons in motor functions remains unsolved. On this matter, divergent conclusions from a wide variety of experimental approaches, ranging from lesion studies to pharmacological approaches, together with the neurochemical heterogeneity that characterizes the PPN, suggest that some of the motor functions assumed to be associated with the cholinergic neurons may be carried out by other cell populations. Even more elusive has been the role of cholinergic neurons in cognitive functions given the difficulties in dissecting the cholinergic nature of the contributions of the PPN to behavior. New technologies and experimental advances have produced exciting data in the past years. On this basis, we aimed to reassess the question of whether cholinergic neurons of the PPN contribute to cognitive or motor functions by revisiting classic PPN studies in light of recent publications and evaluate the evidence that support each case. We then use evidence gathered from clinical studies to interpret the contribution of cholinergic neurons to normal brain operations and the consequences of their dysfunction in disease, setting all this in the context of the experimental data generated in animals. Finally, in the conclusions, we debate on whether a dichotomic approach is the best way to understand the PPN cholinergic neurons.

Motor functions of cholinergic neurons

The PPN, together with the cuneiform nucleus (CnF), traditionally constitute the mesencephalic locomotor region [MLR, (Whelan, 1996)]. This region, located in the midbrain, is defined functionally rather than anatomically: electrical stimulation of the MLR and surrounding areas of decerebrate animals induces stepping on a treadmill. Graded electrical stimulation increased the extensor tone and with continuous stimulation this evolved into coordinated stepping. Increasing stimulation elicited faster gait patterns (Shik et al., 1966). However, in the past, several experimental papers challenged the question of whether the PPN is indeed directly involved in motor control and if it should be considered part of the MLR, and very thorough reviews have been published on that topic (Winn, 2006, 2008). Neither partial, nor complete, nor selective cholinergic lesions of the PPN caused changes in spontaneous locomotion, in locomotion elicited by d-amphetamine or apomorphine, or deficits in individual gait parameters (Gut and Winn, 2015; Inglis et al., 1994a, 1994b; MacLaren et al., 2014; Steiniger and Kretschmer, 2004; Swerdlow and Koob, 1987). In recent years, however, new evidence shed light onto the question of the role of the PPN in motor functions.

PPN cholinergic neurons mediate motor inhibition

Recent optogenetic experiments have shown that activation of glutamatergic neurons of the MLR, but not cholinergic, produces a locomotor response. Transduction of the excitatory opsin channelrhodopsin-2 (ChR2) in the glutamatergic neurons of the PPN and CnF elicited an increase in locomotion that resembles the dynamics of the activation induced by electrical stimulation (Roseberry et al., 2016). The effect on motor activity was observed both, in animals that were not moving, and in animals that were already moving, thus suggesting a role in initiation and maintenance of locomotion. Subsequently, a different study aimed to separate the differences between the two structures that compose the MLR and reported functional differences between PPN and CnF. Using targeted injections for each structure and optogenetic stimulation during a locomotor task, the authors showed that CnF induces higher running speeds than PPN and drives a switch in the locomotion pattern, from walking to gallop. In contrast, PPN was shown to increase locomotion gradually and it was proposed to mediate exploratory locomotion. After chemogenetic inhibition of glutamatergic neurons of either the CnF or PPN, only glutamatergic PPN inhibition decreased overall locomotion and exploratory head-dips in a hole-board test, designed to encourage exploratory behavior (Caggiano et al., 2018). More recently, another study aimed to compare the effects of PPN and CnF activation on muscle activity. Similarly, using an optogenetic strategy, the authors show that only CnF is able to initiate locomotion whereas activation of glutamatergic neurons of the PPN inhibits locomotion by disrupting the locomotor cycle [i.e., disruption of the extensor-flexor cycle; (Josset et al., 2018)]. Altogether, the studies above confirm the existence of the MLR as a functionally-defined area involved in the control of locomotion through its descending projections and suggest that the effects of their activation are correlated with their pattern of connectivity with descending motor systems. In summary, these data put the glutamatergic neuron population at the center of the functional role of the MLR. It then remains to be answered what the role of the cholinergic neurons in the function of the MLR is, and whether they can be considered part of this functionally specialized area.

Studies by Grillner and colleagues in the lamprey demonstrated that, in fact, PPN cholinergic neurons do not belong to the MLR. In an elegant study they show that the connectivity of the MLR largely avoids the cholinergic neurons of the midbrain, otherwise identified as PPN. After injections in the middle rhombencephalic reticular nucleus, no cells were labeled within the area that is defined as the PPN. Only labeled fibers are observed passing through the PPN, thus supporting the claim that PPN and MLR are two separate structures, at least in terms of connectivity. However, cholinergic neurons of the isthmic cell group have descending projections and might intermingle with PPN cholinergic neurons in other species (StephensonJones et al., 2012). Interestingly, there has been some debate about the existence of an area so-called midbrain extrapyramidal area (MEA), which situates medially to the PPN in the rodent, receives dense innervation from the output of the basal ganglia (Rye et al., 1987; Sherman et al., 2015; Steiniger and Kretschmer, 2004; Steininger et al., 1992) and is involved in locomotion (Churchill and Kalivas, 1999). The function of the MEA, however, is not well understood. What is clear from these early studies is that PPN and MEA are different areas: MEA does not contain cholinergic neurons and, despite MEA receiving denser innervation from the substantia nigra pars reticulata and the subthalamic nucleus, PPN maintains close reciprocal connections with the basal ganglia, which rely predominantly on the cholinergic neurons (see the following section). Is there a motor role of PPN cholinergic neurons? PPN cholinergic neurons have descending projections that target lower brainstem regions, including the nucleus pontis oralis (PnO) and the nucleus pontis caudalis (PnC) (Garcia-Rill et al., 2001), the gigantocellular nucleus (Grofova and Keane, 1991; Martinez-Gonzalez et al., 2014) and medial reticular formation (Nakamura et al., 1989). Furthermore, axon collaterals from PPN cholinergic neurons reach the medulla and spinal cord (Rye et al., 1988; Skinner et al., 1990; Spann and Grofova, 1989). A series of experiments in the decerebrate cat by Takakusaki and colleagues have shown that electrical stimulation of the PPN elicit a reduction of the muscle tone of the soleus muscle that is sensitive to the cholinergic muscarinic antagonist atropine sulfate (Takakusaki et al., 2003, 2016). Recent optogenetic experiments in awake mice have shown mixed results following the activation of PPN cholinergic neurons on locomotor activity, ranging from a mild increase in locomotion in head-fixed animals on a trackball only when mice were already moving (Roseberry et al., 2016), to a reduction in locomotion in freely-moving mice (Josset et al., 2018). The latter experiment went further to examine the muscle groups that were susceptible of cholinergic manipulation and identified an increase in the activity of extensor muscles without significantly affecting the flexors. This translated in a reduction in motor activity when PPN cholinergic neurons were activated. It is important to note that the interaction between cell types in the PPN needs to be further characterized in order to rule out the possibility that the effects observed are the consequence of such interaction.

In agreement with the above findings, a series of experiments have explored the role of the ascending collaterals of PPN cholinergic neurons on basal ganglia activity. The collaterals of cholinergic neurons that innervate basal ganglia targets are believed to originate from the same neurons that also innervate descending targets, according to single-cell reconstructions (MenaSegovia et al., 2008). Thus, PPN cholinergic neurons provide afferents to all the components of the basal ganglia: striatum (Dautan et al., 2014, 2016a), external globus pallidus (Charara and Parent, 1994; Eid et al., 2016; Woolf and Butcher, 1986), internal globus pallidus (Shink et al., 1997), subthalamic nucleus (Bevan and Bolam, 1995; Kita and Kita, 2011), substantia nigra pars reticulata [SNr; (Gould et al., 1989; Lavoie and Parent, 1994)] and substantia nigra pars compacta [SNc; (Bolam et al., 1991; Clarke et al., 1987)]. However, only a few of these projections have been functionally characterized. In the striatum, for instance, our lab has identified a direct connection between PPN cholinergic neurons and different types of striatal neurons, including spiny projection neurons (SPNs, the main striatal output neuron) and cholinergic interneurons (CINs). Activation of PPN cholinergic axons in vivo produces an increase in the firing rate of CINs and a decrease in the discharge of SPNs (Dautan et al., 2018). While the full impact of the functional consequences of such activation still needs to be determined, these results suggest that PPN cholinergic neurons are able to interfere with the striatal output by directly inhibiting its projection neurons. This may represent a mechanism by which PPN is able to interrupt motor programs in striatal circuits. In line with this, a recent study elegantly demonstrated a cholinergic-mediated mechanism by which PPN afferents to the SNr are able to act upon the axon terminals from direct pathway SPNs. Thus, modulation of M4 muscarinic receptors decreases the inhibitory drive from SPNs on the SNr, therefore disinhibiting the GABAergic output from the SNr and in turn decreasing the motor output from the basal ganglia (Moehle et al., 2017). Altogether, the combined evidence suggests that axon collaterals from PPN cholinergic neurons may be acting postsynaptically on SPNs to reduce their firing rate, and presynaptically on the SPN’s axon terminals in the SNr to reduce the release of GABA. Other connections originated from cholinergic axons collaterals remain to be explored in detail. For example, while it is known that PPN excites STN neurons (Capozzo et al., 2009; Hammond et al., 1983), the effect of such activation on the basal ganglia network activity is not yet known. Based on the predictions of the basal ganglia connectivity model, excitation of STN neurons would increase activity in SNr (Alexander and Crutcher, 1990; Obeso and Lanciego, 2011), therefore synergizing with the reduced inhibition arising in direct pathway SPNs. In summary, the net effect of PPN cholinergic activation on basal ganglia circuits seems to reduce motor behavior.

Nevertheless, an important component of the basal ganglia circuitry has not yet been considered in the premises above. Cholinergic neurons project to the dopamine neurons of the midbrain (SNc and ventral tegmental area, VTA), which in turn provide dense innervation to the dorsal and ventral striatum (see details below). In terms of motor behavior, activation of cholinergic axons arising in the PPN and the laterodorsal tegmental nucleus (LDT) elicit locomotion in an open field (Xiao et al., 2016), and this is likely mediated by dopamine release in the striatum. If this were a pure motor response, it would result counterintuitive in light of the evidence of motor inhibition described above that seems to be mediated and complemented by both ascending (through striatal targets and basal ganglia output nuclei) and descending targets (mediating increased extensor activity and disruption of the muscle cycle). Based on all the above, we propose that the role of cholinergic neurons is not to mediate motor activity but rather to select and reinforce selective behavioral outputs, thus playing a central role in adaptive behavior.

Cognitive functions of cholinergic neurons

There is abundant evidence that supports a role for cholinergic neurons in cognitive functions beyond their traditionally accepted involvement in saliency and arousal. An extensive number of papers have aimed to dissect the functions of different subtypes of PPN neurons and, more recently, the contribution of cholinergic neurons to adaptive behavior. For example, non-selective lesions of PPN neurons impair the learning of operant responding for rewards. When the task was simple (e.g. every lever press delivers a pellet), or when the animals were pretrained prior to the lesions, they could execute the task in order to receive rewards (Alderson et al., 2002, 2004). However, when the contingencies changed (e.g., when the reinforcement schedule became more complex and the animals received the reward after a random number of presses but on average every 8 presses) or during extinction, the lesioned rats were not able to successfully update their behavior and/or made many errors of perseveration and anticipation (Alderson et al., 2002; Wilson et al., 2009). Future experiments should define the specific role of cholinergic neurons in this function and whether local inflammation may have spread into neighboring regions. In the following sections, we will expand on recent evidence that suggest that PPN, and in particular cholinergic neurons, play a role in signaling reward prediction and shape behavioral flexibility.

Contribution of cholinergic neurons to reward prediction error signaling

Dopaminergic reward prediction error (RPE) signaling is fundamental to understand the role of the PPN in associative learning. The most prominent feature of dopamine neurons is their change in discharge mode from tonic to burst firing in response to unexpected rewards or a reward predicting stimulus (conditioned stimulus, CS) once this association has been established (Hyland et al., 2002; Schultz, 1998). When an expected reward is omitted, neuronal firing of dopamine neurons is suppressed. This RPE, which signals the mismatch between expectation and outcome, is crucial for reward-related associative and reinforcement learning. It informs the organism which stimulus is associated to a reward – in the case of a positive RPE – and which stimulus is no longer followed by a reward – constituting the negative RPE. The capability of dopamine neurons to provide such teaching signal therefore depends on their encoding of the probability (or rather uncertainty) of a reward and the value of the signal.

Neurons that encode a reward prediction need to be able to distinguish between the probability of reward delivery and, therefore, uncertainty. Indeed, Schultz and colleagues have shown that dopamine neurons can differentiate between different reward delivery probabilities. Fully predicted rewards were followed by little to no response in the firing of dopamine neurons, whereas rewards that followed stimuli that did not fully predict a reward, elicited phasic activation of dopamine neurons. The more unlikely (lower probability) the delivery of a reward after a stimulus, the higher the response to the reward (Fiorillo et al., 2003). However, some dopamine neurons do not show phasic, but rather sustained activation after stimuli with variable probability for a reward. The higher the uncertainty (e.g. 50% probability of reward delivery), the larger the change in neuronal activity.

To signal the value of an upcoming outcome, dopamine neurons also need to be able to distinguish between positive and negative outcomes. As mentioned above, dopamine neurons increase their firing in response to a positive outcome (i.e., a reward). In order to signal the value of an outcome, dopamine neurons should in addition be inhibited by negative outcomes. Whilst some studies could support this theory by showing that dopamine neurons are inhibited by aversive stimuli (Tan et al., 2012; Ungless et al., 2004), others have shown that some neurons were also excited by aversive stimuli [such as airpuff-predicting stimuli, (Brischoux et al., 2009; Matsumoto and Hikosaka, 2009)]. Matsumoto and colleagues classified dopamine neurons in two groups: in the first group, neurons represent motivational value, thus increasing their activity during reward expectation and decreasing activity during punishment or stimuli predicting aversive events; in the second group, neurons increase their firing rate also during both punishments (e.g. an airpuff) or their predictive stimuli after conditioning. The authors speculate that this group of dopamine neurons indicate the motivational salience of the CS. This way, dopamine neurons could also be indicating the need for a behavioral (orienting) response in response to salient stimuli, without encoding for the value of the information carried by the stimulus (Matsumoto and Hikosaka, 2009). Different dopamine neuron populations (based on projection target or input sources) might therefore integrate information differently and have different functions in the mechanism with which the organism orients its behavior towards salient stimuli.

Cholinergic neurons innervate dopamine midbrain neurons, as mentioned before. Microinjections of muscarinic and nicotinic agonists into the SNc resulted in extended dopamine efflux in the striatum. Blaha and colleagues showed that this cholinergic effect was associated with PPN activity: electrical stimulation of the PPN elicited a tri-phasic response of dopamine efflux that was mediated by nicotinic, muscarinic and glutamatergic receptors in the midbrain (Blaha and Winn, 1993; Forster and Blaha, 2003). Local administration of scopolamine into the PPN produced a similar effect on dopamine release in the striatum in a dose-dependent manner (Chapman et al., 1997). Accordingly, stimulation of the PPN by local injection of bicuculline caused an increase in dopamine neurons burst firing, whilst inactivation of the PPN by means of muscimol decreased bursting activity in the VTA (Floresco et al., 2003). More recent studies expanded on these results and offered a more detailed insight into the mechanisms of PPN influence over dopamine neurons activity. The PPN provides fast excitatory input to midbrain dopamine neurons mediated by glutamatergic transmission (Dautan et al., 2016b; Galtieri et al., 2017), and a slower and sustained excitatory input mediated by acetylcholine (Dautan et al., 2016b), thus influencing their firing mode by eliciting burst firing and inducing dopamine release in the striatum. Optogenetic stimulation of PPN cholinergic terminals in the SNc and VTA increases dopamine neuron firing (Dautan et al., 2016b; Xiao et al., 2016) and switch their firing pattern from tonic to phasic, or vice versa, depending on the previous state of the neuron (Dautan et al., 2016b). Notably, stimulation of cholinergic PPN neurons triggers locomotion only in the SNc but not in the VTA [(Xiao et al., 2016); only LDT axons had an effect on locomotion in the VTA; (Dautan et al., 2016b)]. In contrast to these locomotor effects triggered by the PPN in the SNc, stimulation of PPN cholinergic axons in the VTA caused conditioned place preference (CPP) in a biased version of the CPP task (Xiao et al., 2016) and attenuated extinction when the natural reward was replaced by optogenetic stimulation (Dautan et al., 2016b). Furthermore, photoinhibition of cholinergic PPN neurons that are projecting to the VTA caused severe learning deficits in an appetitive Pavlovian conditioning task (Yau et al., 2016).

The dynamics of PPN neurons is remarkably similar to the response to rewards and conditioned stimuli observed in dopamine neurons. Okada and Kobayashi have shown in a series of studies that PPN neurons in monkeys performing reward-biased saccade tasks respond robustly to the coding of reward-related cues and the value of the reward that follows the cue. PPN neurons showed tonic increases or decreases during task execution. Further, some of the tonic excitatory neurons differentially encoded for predicted reward magnitude, showing a stronger response to large reward predicting cues than to small reward predicting cues, which indicates the ability to predicting the value of a future reward (Okada et al., 2009). In a recent study, PPN neurons that were monosynaptically connected to SNc dopamine neurons, as determined by modified rabies virus-based retrograde trans-synaptic tracing in genetically-tagged dopamine neurons, PPN neurons were observed to be functionally heterogeneous (Tian et al., 2016). Their activity was recorded during a stimulus-outcome association task. PPN neurons were very heterogeneous in their activity during the task. In response to reward-predicting cues some neurons showed phasic, others sustained excitation; some showed inhibition or even bi-phasic responses. It needs to be pointed out that this study did not differentiate between the different cell-types of the recorded neurons. Further, the activity of SNc-projecting PPN neurons did not only change in response to conditioned stimuli (i.e. encoding expectation) but also to reward or both. This means that the PPN as a structure is able to provide the two types of information to dopamine neurons that they need to compute RPEs: the value of the predicted reward and the actual value of the delivered reward. A proportion of PPN neurons were observed to code positively for reward-predicting cues, meaning increasing their firing rate response with increasing reward probabilities.

Because of the dynamic of activation of cholinergic neurons in response to rewarding events (Okada et al., 2009; Pan and Hyland, 2005; Thompson and Felsen, 2013) and because of the excitatory effects on dopamine phasic transmission (Dautan et al., 2016b; Xiao et al., 2016), it is possible that the signaling of positive RPE may originate in cholinergic neurons, but further experiments are necessary to generate conclusive evidence. The evidence presented here then supports a role for cholinergic neurons in signaling a better-than-expected outcome and therefore promoting actions that lead to better outcomes; in order words, PPN cholinergic neurons may be reinforcing actions.

Role of the PPN cholinergic neurons in behavioral flexibility

Cholinergic signaling in the brain has been associated with behavioral flexibility. Across different brain areas, release of acetylcholine or pharmacological activation of cholinergic receptors have been shown to facilitate the integration of new learning into neuronal ensembles encoding old learning. Conversely, disruption of cholinergic transmission impairs the ability to switch between behavioral sequences. Neurological conditions where the cholinergic neuronal systems are impaired illustrate this further (e.g., Alzheimer disease, cholinergic-based dementia, progressive supranuclear palsy; see next section). Among these cholinergic systems, the role of the midbrain is not well understood yet. This is due in part to the complex connectivity of its neurons, which provide a sparse, long-range axonal innervation of a wide variety of heterogeneous targets [for a review see (Martinez-Gonzalez et al., 2011)]. Recent studies, however, support their involvement in behavior, and in particular, in cognitive processes associated to the adaptation of behavior in response to changing contingencies, or in other words, cognitive flexibility.

Acetylcholine in the striatum has been shown to mediate place and response reversal learning, attentional and behavioral set-shifting, strategy shifting and reversal learning of contingencies (Aoki et al., 2015; Apicella, 2002; Bradfield et al., 2013; Brown et al., 2010a; Ragozzino and Choi, 2004; Ragozzino et al., 2002, 2009; Tzavos et al., 2004; Zucca et al., 2018). As described in the previous section, striatal acetylcholine was believed to originate exclusively from CINs, but an unaccounted source was found to arise in the cholinergic midbrain (Dautan et al., 2014) and target CINs, thus providing an additional mechanism to regulate cholinergic transmission in striatal circuits. Experiments in our lab were recently aimed to determine whether the actions from these two cholinergic systems (intrinsic vs extrinsic) were complementary or served similar functions. In an instrumental task to evaluate action shifting dependent on cholinergic transmission, the release of acetylcholine was selectively blocked during the training of the task in either striatal neurons or PPN/LDT neurons using a chemogenetic strategy. Subsequently, the animals were pre-exposed to the reinforcer and tested in the same tasks they were trained in. The results revealed that acetylcholine in the dorsolateral striatum is critical to encode habitual learning, whereas in the dorsomedial striatum is necessary to encode goal-directed learning. Furthermore, the results showed that the same effects were obtained by either blocking the activity of CINs or blocking the activity of PPN/LDT (Dautan et al., 2018). Because the latter is capable of modulating the activity of CINs, this suggests a hierarchical control of midbrain projections over CINs and, consequently, over the striatal output, since CINs are able to modulate the activity of SPNs. In summary, these results suggest that PPN/LDT exert control over action selection at the level of the striatum. Notably, the same experimental manipulation (i.e. inhibition of acetylcholine release in the striatum from midbrain axon terminals) did not produce any effect on locomotor activity, thus supporting the contribution of midbrain cholinergic neurons to the selection of behavior.

In addition to their direct influence over striatal circuits, midbrain cholinergic neurons can also potentially influence behavior through thalamic circuits. The thalamus has traditionally been considered a structure that conveys subcortical information to the cerebral cortex and relays efferent copies of motor programs originated in the cortex (Sherman and Guillery, 2002, 2011). Neurons of the parafascicular thalamic nucleus (PF) selectively activate CINs by means of glutamate release (Ding et al., 2010). The activation of CINs mediated by PF neurons has been associated with cognitive flexibility (Brown et al., 2010b), suggesting that the role of CINs in cognitive flexibility is regulated by thalamic inputs. Indeed, pharmacological inactivation by means of the GABA agonists baclofen and muscimol of PF neurons impaired specifically reversal learning in a T-maze task: the same manipulation had no effect on the mere acquisition of place discrimination in the maze. However, baclofen/muscimol-injected rats required more trials to learn the reversed contingencies and made significantly more regressive errors than controls. In the same lines, inactivation of the PF inhibited the increase in dorsomedial striatal cholinergic efflux during the reversal learning phase observed in controls, but not during the first acquisition phase (Brown et al., 2010a). Activation of thalamostriatal projecting neurons caused a burst/pause firing pattern in CINs, which led to a transient interruption of cortical signaling to SPNs through presynaptic M2 receptors followed by a period of enhanced responsiveness in D2 (but not D1) SPNs through postsynaptic facilitation. Given that this facilitation was occurring during the firing pause of the CINs, this could constitute a mechanism of redirection of attention and disrupting of ongoing motor behavior (acting on the indirect pathway) with the presentation of a salient stimulus: The fast activation of presynaptic corticostriatal M2 receptors reduces glutamatergic release at corticostriatal terminals on SPNs, whilst the responsiveness of D2 SPNs enhances the ‘no go’ signal (Ding et al., 2010), causing the required cessation of ongoing behavior necessary for updating and changing motor behavior in response to changing contingencies. In a series of carefully designed experiments, Balleine and colleagues showed that manipulating the thalamostriatal pathway with consequential disturbance of cholinergic function in the striatum impaired rodents’ ability to update initially learned action-outcome sequences (Bradfield et al., 2013). Rats with PF lesions showed no difficulties learning a task but were unable to adapt to changes in the contingencies, whether these were changes due to contingency degradation, extinction or reversal of contingencies.

Thus, cholinergic axons from the PPN and LDT innervate profusely several thalamic structures and are able to modulate the thalamic communication with the cortex and the striatum. In particular, cholinergic axons densely innervate the PF. This cholinergic input is believed to produce an excitatory effect that triggers fast-frequency oscillations typically associated with arousal signals. Whether the PPN cholinergic input determines the activity of thalamostriatal neurons that in turn regulate the activity of CINs is not known yet, but the dense innervation of the PF (Parent and Descarries, 2008) suggests that this may be the case. Data from behavioral experiments supports this assumption: PPN non-selective lesions or pharmacological inactivation lead to increased perseverance in an operant task and impaired action-outcome associations (Maclaren et al., 2013; Wilson et al., 2009), suggesting that PPN has a strong modulatory influence over behavioral set shifting, possibly mediated via its connectivity with PF thalamostriatal neurons and therefore suggesting a role in cognitive flexibility.

In summary, the available evidence suggests the existence of two mechanisms by which midbrain cholinergic neurons arising in the PPN and LDT influence the activity of CINs in the striatum and shape behavioral flexibility. The first one is direct through the modulation of the activity of CINs by monosynaptic connections, and the second one is indirect through the putative activation of thalamic circuits that in turn project to the striatum and activate striatal interneurons, most notably CINs. Together with the evidence from experimental manipulations in animals described above, suggesting a thalamic role in behavioral flexibility [i.e. (Bradfield et al., 2013; Brown et al., 2010a)], further evidence arises from human studies in patients who have suffered neurological damage in thalamic structures. For example, lesions in the anterior thalamic groups have been associated with perseverative behavior (Carrera and Bogousslavsky, 2006). Moreover, additional evidence is supported by the diminished cholinergic transmission observed in some neurodegenerative disorders, as will be further developed in the following section. Therefore, both experimental and clinical evidence support a role of cholinergic transmission in the thalamus in cognitive flexibility.

Dysfunction of midbrain cholinergic neurons

Similar to the debate regarding motor functions of the PPN, there has been a prominent interest in whether the PPN plays a significant role in the development of certain movement deficits in PD and progressive supranuclear palsy (PSP). In the PPN, there is cholinergic and noncholinergic (glutamatergic and GABAergic) cell loss in idiopathic PD, as well as in PSP and multiple system atrophy (MSA), which are neurological disorders that can develop into atypical parkinsonian forms where severe impairment of gait and balance are prominent features (Hirsch et al., 1987; Jellinger, 1988; Rinne et al., 2008; Schmeichel et al., 2008). Human post mortem brainstem samples revealed a lack of markers of glutamate transporters in the PPN in PSP (Eser et al., 2018; no data is available in PD), suggesting a reduced glutamatergic function, which was combined with a high proportion of tau-bearing neurons. In PD, the activity of the remaining neurons in the PPN has been shown to be altered, the techniques used in these studies did not allow to differentiate between different neuronal subtypes (Aravamuthan et al., 2008; Mitchell et al., 1989; Orieux et al., 2000). In old, but not young, MPTP-treated monkeys, dopaminergic cell loss was accompanied by loss of PPN cholinergic neurons (Karachi et al., 2010), although this has not been a consistent finding. Nevertheless, old MPTP monkeys show more marked postural deficits than the younger MPTP-treated monkeys, where PPN degeneration has not been observed. After lesioning the PPN (without causing DA cell loss), gait and postural deficits developed (Karachi et al., 2010). Because PD is associated with impaired activity in the basal ganglia circuit (Avila et al., 2010; Brown, 2006; Weinberger et al., 2009), this evidence suggests a role of the PPN in the pathophysiology of the movement disorders that characterize parkinsonism. Nonetheless, non-selective lesions of the PPN in rodents did not lead to any measurable gait or postural deficits (Gut and Winn, 2015). Neither combined dopamine denervation with partial PPN lesions, nor PPN lesions alone, showed any noticeable changes in gait deficits in comparison with the traditional model of nigrostriatal degeneration (6-hydroxydopamine lesions of the SNc). Notably, however, the additional damage produced by the implantation of an electrode for DBS in the PPN induced freezing of gait (even off-stimulation), a cardinal sign of PD. The presence of freezing of gait was only during contextual movement, or in other words, when animals were trained to run along a corridor. While the lesions were not cell-type specific, these results suggest that the contribution of the PPN to motor behavior is contingent on the environmental demands and the required adaptations to elicit a behavioral output.

As part of the symptomatology that appears in the late stages of PD, falls can develop from different complications and are often the result of postural instability or the occurrence of freezing of gait. Freezing of gait is a complex symptom that occurs in the absence of L-dopa medication (off-medication) and occasionally in some patients also during L-dopa treatment. It is described as “an episodic absence or marked reduction of forward progression of the feet, despite the intention to walk” (Nutt et al., 2011). This motor feature is often triggered during particular circumstances, such as when patients are challenged by an obstacle in their path, when crossing a door frame, when turning direction or during dual-task situations. During these challenging moments, the additional sensory inputs that need to be integrated with the motor program do not seem to be processed efficiently. Interestingly, patients with significant thalamic cholinergic denervation showed more pronounced deficits of signal detection in a signal detection task that measures perceptual sustained attention under additional attentional challenges (using perceptual distractors), compared to PD patients with normal thalamic cholinergic signaling or healthy controls (Kim et al., 2017). This suggests that difficulties to integrate sensory information into motor control due to decreased thalamic cholinergic innervation might be a contributing factor for gait and postural symptoms. In support of this, Mueller and colleagues found that only thalamic cholinergic signaling correlated significantly with the ability to use sensory feedback to maintain balance (Muller et al., 2013).

Despite the extensive literature on the impairment of PPN function in PD, clinical and post mortem studies are limited in determining how much of the PPN-driven dysfunction is due to cholinergic cell loss. As reviewed in the previous sections, PPN glutamatergic neurons play a fundamental role in the control of movement as part of the MLR. In contrast, the experimental evidence discussed earlier suggests that the role of cholinergic neurons may be more closely related with cognitive functions. In line with this, cognitive symptoms seem to correlate with a loss of cholinergic tone in the basal ganglia and the thalamus. The variable pattern of basal forebrain and brainstem cholinergic denervation, measured as a lower acetylcholinesterase (AChE) activity in cortex and thalamus, respectively, seems to correlate with clinical features of PD patients. Low cortical AChE activity occurs more prominently in patients with lower cognitive performance whilst patients with low thalamic AChE activity show a higher propensity for falls (Bohnen et al., 2012). In an earlier study, Bohnen and colleagues investigated the relationship between cholinergic activity in cortex and thalamus and the propensity of falls in PD patients. They report that patients with a history of falls had significantly lower cortical and thalamic AChE activity than non-fallers or control subjects (Bohnen et al., 2009). In line with these findings, post mortem studies reported more severe PPN cholinergic cell loss in PD fallers compared to non-fallers (Karachi et al., 2010). Additional clues of the role of the midbrain cholinergic function may arise from the evidence in PSP.

PSP is an atypical parkinsonian syndrome with severe cognitive and motor impairments, the latter characterized by alterations of gait and balance that are typically non-responsive to dopaminergic medication. The neuropathology of PSP is characterized by a marked neural degeneration and widespread atrophy in the brainstem, basal ganglia and intralaminar thalamus (of which the PF forms part; (Henderson et al., 2000; Steele et al., 1964)). What distinguishes this disorder and makes it relevant for the current review is that the degeneration occurs first and predominantly in cholinergic neurons of the midbrain over the course of the disease (Hirsch et al., 1987). Immunohistochemical detection of the synthetic enzyme of acetylcholine (choline acetyltransferase, ChAT) has been reported to be markedly reduced in the PPN and LDT (Kasashima and Oda, 2003), but also in the striatum, nucleus accumbens and substantia innominata (Ruberg et al., 1985). The reduction in the number of PPN cholinergic neurons was found to be as high as 60%, according to post mortem studies (Warren et al., 2005), which was accompanied by a significant number of tau-positive neurons (Eser et al., 2018). Furthermore, thalamic AChE activity is lower in PSP than in PD patients, as measured by AChE positron emission tomography (Gilman et al., 2010), indicating a greater loss of cholinergic PPN neurons in PSP. In addition to the parkinsonian motor symptoms, PSP patients show prominent cognitive impairments, including dementia, and perseverant responses (Brown et al., 2010b). Approximately 70% of PSP patients will show a form of dementia and executive function deficits are the most common cognitive deficit. Apathy and impulsivity are features often observed in PSP and support its diagnosis (Burrell et al., 2014). Thus, these cognitive symptoms in PSP patients are in agreement with the effects of reduced cholinergic transmission in basal ganglia and thalamic circuits and further support the role of PPN cholinergic neurons in action control.

In summary, both the clinical and the experimental data point towards a complex influence of the PPN on motor output, suggesting that the major impairment lies in the integration of new sensory input and adaptation to changes in the environment, which require an adjustment of the motor output and the selection of a suitable motor program.

Conclusions

Here we have reviewed evidence that supports roles of cholinergic neurons in both motor and cognitive functions. Those motor functions, however, do not fit with the classic notion of the MLR and they rather seem to contribute to motor inhibition. In agreement with this, the ascending connectivity of cholinergic neurons with basal ganglia structures support a role in stopping actions (at the level of the SNr and the striatum). Then, on the other hand, cholinergic neurons contribute to goal-directed locomotion and the reinforcement of actions through their connections with dopamine neurons. How can all this evidence be put together in a single theory of cholinergic neurons?

When environmental contingencies change and a certain action no longer leads to a positive outcome, i.e. is no longer adaptive, the organism needs to pay attention to the new stimuli and/or the changed outcomes that are related to a specific action, in order to change the response selection. Stopping an old action and reinforcing a new action are key mechanisms that underlie flexible behavior. PPN cholinergic neurons may contribute to both mechanisms by constituting an interface between motor and cognitive functions, thus accessing the motor systems that are recruited during changing contingencies. In this context, cholinergic neurons may be required to provide a constant update of action-outcome associations, which requires them to signal motivational salience and valence of a stimulus to the dopaminergic system. They further need to signal a mismatch between expected and real outcome, stop specific actions, for the organism to pay attention to new stimuli and changed contingencies, and to reinforce new actions. When the mechanisms that are dependent on cholinergic neurons fail, the updating process is incomplete, leading to impaired sensorimotor integration (e.g. freezing of gait and falls) and perseverant behavior, as observed in both PD with cholinergic degeneration and PSP, which are characterized with disrupted activity in basal ganglia circuits. New directions in PPN research should thus aim to test the role of cholinergic neurons of the midbrain as critical integrators in the basal ganglia that are necessary for efficient updating of action-outcome associations for adaptive response selection.

Acknowledgements

This work was supported by an NIH grant (NS100824–01) and a Young Investigator Award from the Brain and Behavior Research Foundation (NARSAD).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Alderson HL, Brown VJ, Latimer MP, Brasted PJ, Robertson AH, and Winn P (2002). The effect of excitotoxic lesions of the pedunculopontine tegmental nucleus on performance of a progressive ratio schedule of reinforcement. Neuroscience 112, 417–425. [DOI] [PubMed] [Google Scholar]
  2. Alderson HL, Latimer MP, Blaha CD, Phillips AG, and Winn P (2004). An examination of d-amphetamine self-administration in pedunculopontine tegmental nucleus-lesioned rats. Neuroscience 125, 349–358. [DOI] [PubMed] [Google Scholar]
  3. Alexander GE, and Crutcher MD (1990). Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13, 266–271. [DOI] [PubMed] [Google Scholar]
  4. Aoki S, Liu AW, Zucca A, Zucca S, and Wickens JR (2015). Role of Striatal Cholinergic Interneurons in Set-Shifting in the Rat. J. Neurosci 35, 9424–9431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Apicella P (2002). Tonically active neurons in the primate striatum and their role in the processing of information about motivationally relevant events. Eur. J. Neurosci 16, 2017–2026. [DOI] [PubMed] [Google Scholar]
  6. Aravamuthan BR, Bergstrom DA, French RA, Taylor JJ, Parr-Brownlie LC, and Walters JR (2008). Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson’s disease. Exp. Neurol 213, 268–280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Avila I, Parr-Brownlie LC, Brazhnik E, Castaneda E, Bergstrom DA, and Walters JR (2010). Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat. Exp. Neurol 221, 307–319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bevan MD, and Bolam JP (1995). Cholinergic, GABAergic, and glutamate-enriched inputs from the mesopontine tegmentum to the subthalamic nucleus in the rat. J. Neurosci 15, 7105–7120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Blaha CD, and Winn P (1993). Modulation of dopamine efflux in the striatum following cholinergic stimulation of the substantia nigra in intact and pedunculopontine tegmental nucleuslesioned rats. J. Neurosci 13, 1035–1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bohnen NI, Muller MLTM, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, and Albin RL (2009). History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 73, 1670–1676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bohnen NI, Muller MLTM, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, and Frey KA (2012). Heterogeneity of cholinergic denervation in Parkinson’s disease without dementia. J. Cereb. Blood Flow Metab 32, 1609–1617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bolam JP, Francis CM, and Henderson Z (1991). Cholinergic input to dopaminergic neurons in the substantia nigra: a double immunocytochemical study. Neuroscience 41, 483–494. [DOI] [PubMed] [Google Scholar]
  13. Bradfield LA, Bertran-Gonzalez J, Chieng B, and Balleine BW (2013). The thalamostriatal pathway and cholinergic control of goal-directed action: interlacing new with existing learning in the striatum. Neuron 79, 153–166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Brischoux F, Chakraborty S, Brierley DI, and Ungless MA (2009). Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc. Natl. Acad. Sci. U. S. A 106, 4894–4899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Brown P (2006). Bad oscillations in Parkinson’s disease. J. Neural Transm Suppl 27–30. [DOI] [PubMed] [Google Scholar]
  16. Brown HD, Baker PM, and Ragozzino ME (2010a). The parafascicular thalamic nucleus concomitantly influences behavioral flexibility and dorsomedial striatal acetylcholine output in rats. J. Neurosci 30, 14390–14398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, et al. (2010b). Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133, 2382–2393. [DOI] [PubMed] [Google Scholar]
  18. Burrell JR, Hodges JR, and Rowe JB (2014). Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov. Disord 29, 684–693. [DOI] [PubMed] [Google Scholar]
  19. Caggiano V, Leiras R, Goni-Erro H, Masini D, Bellardita C, Bouvier J, Caldeira V, Fisone G, and Kiehn O (2018). Midbrain circuits that set locomotor speed and gait selection. Nature 553, 455–460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Capozzo A, Florio T, Confalone G, Minchella D, Mazzone P, and Scarnati E (2009). Low frequency stimulation of the pedunculopontine nucleus modulates electrical activity of subthalamic neurons in the rat. J. Neural Transm 116, 51–56. [DOI] [PubMed] [Google Scholar]
  21. Carrera E, and Bogousslavsky J (2006). The thalamus and behavior: effects of anatomically distinct strokes. Neurology 66, 1817–1823. [DOI] [PubMed] [Google Scholar]
  22. Chapman CA, Yeomans JS, Blaha CD, and Blackburn JR (1997). Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus. Neuroscience 76, 177–186. [DOI] [PubMed] [Google Scholar]
  23. Charara A, and Parent A (1994). Brainstem dopaminergic, cholinergic and serotoninergic afferents to the pallidum in the squirrel monkey. Brain Res. 640, 155–170. [DOI] [PubMed] [Google Scholar]
  24. Churchill L, and Kalivas PW (1999). The involvement of the mediodorsal nucleus of the thalamus and the midbrain extrapyramidal area in locomotion elicited from the ventral pallidum. Behav. Brain Res 104, 63–71. [DOI] [PubMed] [Google Scholar]
  25. Clarke PB, Hommer DW, Pert A, and Skirboll LR (1987). Innervation of substantia nigra neurons by cholinergic afferents from pedunculopontine nucleus in the rat: neuroanatomical and electrophysiological evidence. Neuroscience 23, 1011–1019. [DOI] [PubMed] [Google Scholar]
  26. Dautan D, Huerta-Ocampo I, Witten IB, Deisseroth K, Bolam JP, Gerdjikov T, and Mena-Segovia J (2014). A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem. J. Neurosci 34, 4509–4518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Dautan D, Hacioglu Bay H, Bolam JP, Gerdjikov TV, and Mena-Segovia J (2016a). Extrinsic Sources of Cholinergic Innervation of the Striatal Complex: A Whole-Brain Mapping Analysis. Front. Neuroanat 10, 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Dautan D, Souza AS, Huerta-Ocampo I, Valencia M, Assous M, Witten IB, Deisseroth K, Tepper JM, Bolam JP, Gerdjikov TV, et al. (2016b). Segregated cholinergic transmission modulates dopamine neurons integrated in distinct functional circuits. Nat. Neurosci 19, 1025–1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Dautan D, Huerta-Ocampo I, Valencia M, Kondaboulu K, Gerdjikov TV, and MenaSegovia J (2018). Cholinergic brainstem afferents modulate striatal circuits and shape of action control. Under Rev. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ding JB, Guzman JN, Peterson JD, Goldberg JA, and Surmeier DJ (2010). Thalamic gating of corticostriatal signaling by cholinergic interneurons. Neuron 67, 294–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Eid L, Parent A, and Parent M (2016). Asynaptic feature and heterogeneous distribution of the cholinergic innervation of the globus pallidus in primates. Brain Struct. Funct 221, 1139–1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Eser RA, Ehrenberg AJ, Petersen C, Dunlop S, Mejia MB, Suemoto CK, Walsh CM, Rajana H, Oh J, Theofilas P, et al. (2018). Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study. J. Neuropathol. Exp. Neurol 77, 149–161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Fiorillo CD, Tobler PN, and Schultz W (2003). Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299, 1898–1902. [DOI] [PubMed] [Google Scholar]
  34. Floresco SB, West AR, Ash B, Moore H, and Grace AA (2003). Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat. Neurosci 6, 968–973. [DOI] [PubMed] [Google Scholar]
  35. Forster GL, and Blaha CD (2003). Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat. Eur. J. Neurosci 17, 751–762. [DOI] [PubMed] [Google Scholar]
  36. Galtieri DJ, Estep CM, Wokosin DL, Traynelis S, and Surmeier DJ (2017). Pedunculopontine glutamatergic neurons control spike patterning in substantia nigra dopaminergic neurons. Elife 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Garcia-Rill E, Skinner RD, Miyazato H, and Homma Y (2001). Pedunculopontine stimulation induces prolonged activation of pontine reticular neurons. Neuroscience 104, 455–465. [DOI] [PubMed] [Google Scholar]
  38. Gilman S, Koeppe RA, Nan B, Wang C-N, Wang X, Junck L, Chervin RD, Consens F, and Bhaumik A (2010). Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology 74, 1416–1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Gould E, Woolf NJ, and Butcher LL (1989). Cholinergic projections to the substantia nigra from the pedunculopontine and laterodorsal tegmental nuclei. Neuroscience 28, 611–623. [DOI] [PubMed] [Google Scholar]
  40. Grofova I, and Keane S (1991). Descending brainstem projections of the pedunculopontine tegmental nucleus in the rat. Anat. Embryol. (Berl) 184, 275–290. [DOI] [PubMed] [Google Scholar]
  41. Gut NK, and Winn P (2015). Deep brain stimulation of different pedunculopontine targets in a novel rodent model of parkinsonism. J. Neurosci 35, 4792–4803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Hammond C, Rouzaire-Dubois B, Feger J, Jackson A, and Crossman AR (1983). Anatomical and electrophysiological studies on the reciprocal projections between the subthalamic nucleus and nucleus tegmenti pedunculopontinus in the rat. Neuroscience 9, 41–52. [DOI] [PubMed] [Google Scholar]
  43. Henderson JM, Carpenter K, Cartwright H, and Halliday GM (2000). Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson’s disease: clinical and therapeutic implications. Brain 123, 1410–1421. [DOI] [PubMed] [Google Scholar]
  44. Hirsch EC, Graybiel AM, Duyckaerts C, and Javoy-Agid F (1987). Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc. Natl. Acad. Sci. U. S. A 84, 5976–5980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Hyland BI, Reynolds JNJ, Hay J, Perk CG, and Miller R (2002). Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114, 475–492. [DOI] [PubMed] [Google Scholar]
  46. Inglis WL, Dunbar JS, and Winn P (1994a). Outflow from the nucleus accumbens to the pedunculopontine tegmental nucleus: a dissociation between locomotor activity and the acquisition of responding for conditioned reinforcement stimulated by d-amphetamine. Neuroscience 62, 51–64. [DOI] [PubMed] [Google Scholar]
  47. Inglis WL, Allen LF, Whitelaw RB, Latimer MP, Brace HM, and Winn P (1994b). An investigation into the role of the pedunculopontine tegmental nucleus in the mediation of locomotion and orofacial stereotypy induced by d-amphetamine and apomorphine in the rat. Neuroscience 58, 817–833. [DOI] [PubMed] [Google Scholar]
  48. Jellinger K (1988). The pedunculopontine nucleus in Parkinson’s disease, progressive supranuclear palsy and Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 51, 540–543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Josset N, Roussel M, Lemieux M, Lafrance-Zoubga D, Rastqar A, and Bretzner F (2018). Distinct Contributions of Mesencephalic Locomotor Region Nuclei to Locomotor Control in the Freely Behaving Mouse. Curr. Biol 28, 884–901.e3. [DOI] [PubMed] [Google Scholar]
  50. Karachi C, Grabli D, Bernard FA, Tande D, Wattiez N, Belaid H, Bardinet E, Prigent A, Nothacker H-P, Hunot S, et al. (2010). Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J. Clin. Invest 120, 2745–2754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Kasashima S, and Oda Y (2003). Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 105, 117–124. [DOI] [PubMed] [Google Scholar]
  52. Kim K, Muller MLTM, Bohnen NI, Sarter M, and Lustig C (2017). Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic losses. Neuroimage 149, 295–304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Kita T, and Kita H (2011). Cholinergic and non-cholinergic mesopontine tegmental neurons projecting to the subthalamic nucleus in the rat. Eur. J. Neurosci 33, 433–443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Lavoie B, and Parent A (1994). Pedunculopontine nucleus in the squirrel monkey: projections to the basal ganglia as revealed by anterograde tract-tracing methods. J. Comp. Neurol 344, 210–231. [DOI] [PubMed] [Google Scholar]
  55. Maclaren DAA, Wilson DIG, and Winn P (2013). Updating of action-outcome associations is prevented by inactivation of the posterior pedunculopontine tegmental nucleus. Neurobiol. Learn. Mem 102, 28–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. MacLaren DAA, Santini JA, Russell AL, Markovic T, and Clark SD (2014). Deficits in motor performance after pedunculopontine lesions in rats--impairment depends on demands of task. Eur. J. Neurosci 40, 3224–3236. [DOI] [PubMed] [Google Scholar]
  57. Martinez-Gonzalez C, Bolam JP, and Mena-Segovia J (2011). Topographical organization of the pedunculopontine nucleus. Front. Neuroanat 5, 22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Martinez-Gonzalez C, van Andel J, Bolam JP, and Mena-Segovia J (2014). Divergent motor projections from the pedunculopontine nucleus are differentially regulated in Parkinsonism. Brain Struct. Funct 219, 1451–1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Matsumoto M, and Hikosaka O (2009). Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature 459, 837–841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Mena-Segovia J, Sims HM, Magill PJ, and Bolam JP (2008). Cholinergic brainstem neurons modulate cortical gamma activity during slow oscillations. J. Physiol 586, 2947–2960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, and Crossman AR (1989). Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine. Neuroscience 32, 213–226. [DOI] [PubMed] [Google Scholar]
  62. Moehle MS, Pancani T, Byun N, Yohn SE, Wilson GH 3rd, Dickerson JW, Remke DH, Xiang Z, Niswender CM, Wess J, et al. (2017). Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor. Neuron 96, 1358–1372.e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Muller MLTM, Albin RL, Kotagal V, Koeppe RA, Scott PJH, Frey KA, and Bohnen NI (2013). Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s disease. Brain 136, 3282–3289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Nakamura Y, Tokuno H, Moriizumi T, Kitao Y, and Kudo M (1989). Monosynaptic nigral inputs to the pedunculopontine tegmental nucleus neurons which send their axons to the medial reticular formation in the medulla oblongata. An electron microscopic study in the cat. Neurosci. Lett 103, 145–150. [DOI] [PubMed] [Google Scholar]
  65. Nutt JG, Bloem BR, Giladi N, Hallett M, Horak FB, and Nieuwboer A (2011). Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet. Neurol 10, 734–744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Obeso JA, and Lanciego JL (2011). Past, present, and future of the pathophysiological model of the Basal Ganglia. Front. Neuroanat 5, 39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Okada K, Toyama K, Inoue Y, Isa T, and Kobayashi Y (2009). Different pedunculopontine tegmental neurons signal predicted and actual task rewards. J. Neurosci 29, 4858–4870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Orieux G, Francois C, Feger J, Yelnik J, Vila M, Ruberg M, Agid Y, and Hirsch EC (2000). Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson’s disease. Neuroscience 97, 79–88. [DOI] [PubMed] [Google Scholar]
  69. Pan W-X, and Hyland BI (2005). Pedunculopontine tegmental nucleus controls conditioned responses of midbrain dopamine neurons in behaving rats. J. Neurosci 25, 4725–4732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Parent M, and Descarries L (2008). Acetylcholine innervation of the adult rat thalamus: distribution and ultrastructural features in dorsolateral geniculate, parafascicular, and reticular thalamic nuclei. J. Comp. Neurol 511, 678–691. [DOI] [PubMed] [Google Scholar]
  71. Ragozzino ME, and Choi D (2004). Dynamic changes in acetylcholine output in the medial striatum during place reversal learning. Learn. Mem 11, 70–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Ragozzino ME, Jih J, and Tzavos A (2002). Involvement of the dorsomedial striatum in behavioral flexibility: role of muscarinic cholinergic receptors. Brain Res. 953, 205–214. [DOI] [PubMed] [Google Scholar]
  73. Ragozzino ME, Mohler EG, Prior M, Palencia CA, and Rozman S (2009). Acetylcholine activity in selective striatal regions supports behavioral flexibility. Neurobiol. Learn. Mem 91, 13–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Rinne JO, Ma SY, Lee MS, Collan Y, and Roytta M (2008). Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson’s disease is related to disability of the patients. Parkinsonism Relat. Disord 14, 553–557. [DOI] [PubMed] [Google Scholar]
  75. Roseberry TK, Lee AM, Lalive AL, Wilbrecht L, Bonci A, and Kreitzer AC (2016). CellType-Specific Control of Brainstem Locomotor Circuits by Basal Ganglia. Cell 164, 526–537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Ruberg M, Javoy-Agid F, Hirsch E, Scatton B, LHeureux R, Hauw JJ, Duyckaerts C, Gray F, Morel-Maroger A, and Rascol A (1985). Dopaminergic and cholinergic lesions in progressive supranuclear palsy. Ann. Neurol 18, 523–529. [DOI] [PubMed] [Google Scholar]
  77. Rye DB, Saper CB, Lee HJ, and Wainer BH (1987). Pedunculopontine tegmental nucleus of the rat: cytoarchitecture, cytochemistry, and some extrapyramidal connections of the mesopontine tegmentum. J. Comp. Neurol 259, 483–528. [DOI] [PubMed] [Google Scholar]
  78. Rye DB, Lee HJ, Saper CB, and Wainer BH (1988). Medullary and spinal efferents of the pedunculopontine tegmental nucleus and adjacent mesopontine tegmentum in the rat. J. Comp. Neurol 269, 315–341. [DOI] [PubMed] [Google Scholar]
  79. Schmeichel AM, Buchhalter LC, Low PA, Parisi JE, Boeve BW, Sandroni P, and Benarroch EE (2008). Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology 70, 368–373. [DOI] [PubMed] [Google Scholar]
  80. Schultz W (1998). Predictive reward signal of dopamine neurons. J. Neurophysiol 80, 1–27. [DOI] [PubMed] [Google Scholar]
  81. Sherman SM, and Guillery RW (2011). Distinct functions for direct and transthalamic corticocortical connections. J. Neurophysiol 106, 1068–1077. [DOI] [PubMed] [Google Scholar]
  82. Sherman D, Fuller PM, Marcus J, Yu J, Zhang P, Chamberlin NL, Saper CB, and Lu J (2015). Anatomical Location of the Mesencephalic Locomotor Region and Its Possible Role in Locomotion, Posture, Cataplexy, and Parkinsonism. Front. Neurol 6, 140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Shik ML, Severin FV, and Orlovskii GN (1966). [Control of walking and running by means of electric stimulation of the midbrain]. Biofizika 11, 659–666. [PubMed] [Google Scholar]
  84. Shink E, Sidibe M, and Smith Y (1997). Efferent connections of the internal globus pallidus in the squirrel monkey: II. Topography and synaptic organization of pallidal efferents to the pedunculopontine nucleus. J. Comp. Neurol 382, 348–363. [PubMed] [Google Scholar]
  85. Skinner RD, Kinjo N, Henderson V, and Garcia-Rill E (1990). Locomotor projections from the pedunculopontine nucleus to the spinal cord. Neuroreport 1, 183–186. [DOI] [PubMed] [Google Scholar]
  86. Spann BM, and Grofova I (1989). Origin of ascending and spinal pathways from the nucleus tegmenti pedunculopontinus in the rat. J. Comp. Neurol 283, 13–27. [DOI] [PubMed] [Google Scholar]
  87. Steele JC, Richardson JC, and Olszewski J (1964). Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basa ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol 10, 333–359. [DOI] [PubMed] [Google Scholar]
  88. Steiniger B, and Kretschmer BD (2004). Effects of ibotenate pedunculopontine tegmental nucleus lesions on exploratory behaviour in the open field. Behav. Brain Res 151, 17–23. [DOI] [PubMed] [Google Scholar]
  89. Steininger TL, Rye DB, and Wainer BH (1992). Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies. J. Comp. Neurol 321, 515–543. [DOI] [PubMed] [Google Scholar]
  90. Stephenson-Jones M, Ericsson J, Robertson B, and Grillner S (2012). Evolution of the basal ganglia: dual-output pathways conserved throughout vertebrate phylogeny. J. Comp. Neurol 520, 2957–2973. [DOI] [PubMed] [Google Scholar]
  91. Swerdlow NR, and Koob GF (1987). Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry. Brain Res. 412, 233–243. [DOI] [PubMed] [Google Scholar]
  92. Takakusaki K, Habaguchi T, Ohtinata-Sugimoto J, Saitoh K, and Sakamoto T (2003). Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction. Neuroscience 119, 293–308. [DOI] [PubMed] [Google Scholar]
  93. Takakusaki K, Chiba R, Nozu T, and Okumura T (2016). Brainstem control of locomotion and muscle tone with special reference to the role of the mesopontine tegmentum and medullary reticulospinal systems. J. Neural Transm 123, 695–729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Tan KR, Yvon C, Turiault M, Mirzabekov JJ, Doehner J, Labouebe G, Deisseroth K, Tye KM, and Luscher C (2012). GABA neurons of the VTA drive conditioned place aversion. Neuron 73, 1173–1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Thompson JA, and Felsen G (2013). Activity in mouse pedunculopontine tegmental nucleus reflects action and outcome in a decision-making task. J. Neurophysiol 110, 2817–2829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Tian J, Huang R, Cohen JY, Osakada F, Kobak D, Machens CK, Callaway EM, Uchida N, and Watabe-Uchida M (2016). Distributed and Mixed Information in Monosynaptic Inputs to Dopamine Neurons. Neuron 91, 1374–1389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Tzavos A, Jih J, and Ragozzino ME (2004). Differential effects of M1 muscarinic receptor blockade and nicotinic receptor blockade in the dorsomedial striatum on response reversal learning. Behav. Brain Res 154, 245–253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Ungless MA, Magill PJ, and Bolam JP (2004). Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303, 2040–2042. [DOI] [PubMed] [Google Scholar]
  99. Warren NM, Piggott MA, Perry EK, and Burn DJ (2005). Cholinergic systems in progressive supranuclear palsy. Brain 128, 239–249. [DOI] [PubMed] [Google Scholar]
  100. Weinberger M, Hutchison WD, and Dostrovsky JO (2009). Pathological subthalamic nucleus oscillations in PD: can they be the cause of bradykinesia and akinesia? Exp. Neurol. 219, 58–61. [DOI] [PubMed] [Google Scholar]
  101. Whelan PJ (1996). Control of locomotion in the decerebrate cat. Prog. Neurobiol 49, 481–515. [DOI] [PubMed] [Google Scholar]
  102. Wilson DIG, MacLaren DAA, and Winn P (2009). Bar pressing for food: differential consequences of lesions to the anterior versus posterior pedunculopontine. Eur. J. Neurosci 30, 504–513. [DOI] [PubMed] [Google Scholar]
  103. Winn P (2006). How best to consider the structure and function of the pedunculopontine tegmental nucleus: evidence from animal studies. J. Neurol. Sci 248, 234–250. [DOI] [PubMed] [Google Scholar]
  104. Winn P (2008). Experimental studies of pedunculopontine functions: are they motor, sensory or integrative? Parkinsonism Relat. Disord 14 Suppl 2, S194–8. [DOI] [PubMed] [Google Scholar]
  105. Woolf NJ, and Butcher LL (1986). Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain. Brain Res. Bull 16, 603–637. [DOI] [PubMed] [Google Scholar]
  106. Xiao C, Cho JR, Zhou C, Treweek JB, Chan K, McKinney SL, Yang B, and Gradinaru V (2016). Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways. Neuron 90, 333–347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Yau H-J, Wang DV, Tsou J-H, Chuang Y-F, Chen BT, Deisseroth K, Ikemoto S, and Bonci A (2016). Pontomesencephalic Tegmental Afferents to VTA Non-dopamine Neurons Are Necessary for Appetitive Pavlovian Learning. Cell Rep. 16, 2699–2710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Zucca S, Zucca A, Nakano T, Aoki S, and Wickens J (2018). Pauses in cholinergic interneuron firing exert an inhibitory control on striatal output in vivo. Elife 7. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES